Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Ltd. has released an informational presentation for investors detailing their current research advances, particularly highlighting TLX250’s mechanism of action. The company underscores the presentation’s context with their latest financial report and reminds stakeholders that this information is not for decision-making without personal due diligence. It’s important to note that the presentation contains forward-looking statements and is not intended for release in the United States or where prohibited by law.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
